Login / Signup

A Predictive Noninvasive Single-Nucleotide Variation-Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study.

Nico SeegerStefan GutknechtIrin ZschokkeIsabella FleischmannNadja RothJürg MetzgerMarkus WeberStefan BreitensteinLukasz Filip Grochola
Published in: JMIR research protocols (2024)
DERR1-10.2196/54042.
Keyphrases
  • randomized controlled trial
  • locally advanced
  • squamous cell carcinoma